Physical therapies as an adjunct to Botulinum toxin-A injection of the upper or lower limb in adults following neurological impairment

Systematic Reviews

Volumn 1, Issue 1, 2012, Pages

  Kinnear, Bianca Z ^a  

^a Occupational Therapist specializing in neurological rehabilitation in HammondCare   (Australia)

Author keywords

Botulinum toxin A; Motor Disorder; Neurology; Occupational Therapy; Physical Therapy; Spasticity

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ARM; ARTICLE; ELECTROSTIMULATION; HUMAN; LEG; MOTOR PERFORMANCE; MOVEMENT THERAPY; MUSCLE TRAINING; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PHYSIOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SPASTICITY; SPLINTING; STRETCHING; SYSTEMATIC REVIEW; EVIDENCE BASED MEDICINE; LITERATURE; MULTIMODALITY CANCER THERAPY; OCCUPATIONAL THERAPY; PATHOPHYSIOLOGY;

BOTULINUM TOXINS, TYPE A; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; MUSCLE SPASTICITY; NERVOUS SYSTEM DISEASES; NEUROMUSCULAR AGENTS; OCCUPATIONAL THERAPY; PHYSICAL THERAPY MODALITIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC;

EID: 84876186213     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-1-29     Document Type: Article

References (23)

1. Lance JW. Symposium synopsis 1980, 485-494. Miami: Symposia Specialists, Feldman RG, Young RR, Koella WP, In Spasticity: Disordered Motor Control.
2. Sheean G, Lannin N, Turner-Stokes L, Rawicki B, Snow BJ, Cerebral Palsy Institute Botulinum toxin assessment, intervention and after care for upper limb hypertonicity in adults: international consensus statement. Eur J Neurol 2010, 17:74-93. Cerebral Palsy Institute.
3. Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry 2007, 78:845-848. 10.1136/jnnp.2006.103341, 2117719, 17088333.
4. Cardoso E, Rodrigues B, Lucena R, de Reis Oliveira I, Pedreira G, Melo A. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta- analysis. Arq Neuropsiquiatr 2005, 63:30-33. 10.1590/S0004-282X2005000100006, 15830061.
5. Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry 2000, 69:217-221. 10.1136/jnnp.69.2.217, 1737061, 10896696.
6. Chin TY, Graham HK. Botulinum toxin A in the management of upper limb spasticity in cerebral palsy. Hand Clin 2005, 19:591-600.
7. National Stroke F. Clinical guidelines for stroke management 2010, Available from http://www.strokefoundation.com.au/clinical-guidelines.
8. Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70:1691-1698. 10.1212/01.wnl.0000311391.00944.c4, 18458229, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
9. Hagedorn R. Foundations for Practice in Occupational Therapy 2009, New York: Churchill Livingstone, 2.
10. Hesse S, Brandi-Hesse B, Bardeleben A, Werner C, Funk M. Botulinum toxin A treatment of adult upper and lower limb spasticity. Drugs Aging 2001, 18:255-262. 10.2165/00002512-200118040-00003, 11341473.
11. Kinnear B, Lannin N, Cusick A. The promise and potential of botulinum toxin-A: national survey of therapy practices. Int J Stroke 2011, 6(Suppl. 1):17.
12. Hoare B, Imms C. Upper-limb injections of botulinum toxin-A in children with cerebral palsy: a critical review of the literature and clinical implications for Occupational Therapists. Am J Occup Ther 2004, 58:389-397. 10.5014/ajot.58.4.389, 15315245.
13. Sun SF, Hsu CW, Sun HP, Hwang CW, Yang CL, Wang JL. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair 2010, 24:34-41. 10.1177/1545968309341060, 19729582.
14. Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune TM. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait. Stroke 2008, 39:2803-2808. 10.1161/STROKEAHA.108.516153, 18635841.
15. Karadag-Saygi E, Cubukcu-Aydoseli K, Kablan N, Ofluoqlu D. The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Top Stroke Rehabil 2010, 17:318-322. 10.1310/tsr1704-318, 20826420.
16. The Nordic Cochrane Centre The Cochrane Collaboration 2008, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, Review Manager (RevMan). 5.0, The Nordic Cochrane Centre.
17. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003, 83:713-715.
18. Harvey L, Herbert R, Crosbie J. Does stretching induce lasting increases in joint ROM? A systematic review. Physiother Res Int 2002, 7:1-13. 10.1002/pri.236, 11992980.
19. Schultz KF, Chalmers I, Hayes RJ, Aitman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273:408-412. 10.1001/jama.1995.03520290060030, 7823387.
20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000, 283:2008-2012. 10.1001/jama.283.15.2008, 10789670.
21. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, Higgins JPT, Green S, Available from www.cochrane-handbook.org.
22. Wissel J, Ward AB, Ertzgaard P, Bensmail B, Hecht MJ, Lejeune TM, Schnider P. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009, 41:13-25. 10.2340/16501977-0303, 19197564.
23. Royal College of Physicians London National Guidelines Spasticity in Adults: Management Using Botlulinum Toxin 2009, Aberystwyth: Cambrian Printers Ltd, Royal College of Physicians London.